Seftika Sari
Sekolah Tinggi Ilmu Farmasi Riau, Jl. Kamboja, Simpang Baru-Panam-Pekanbaru, 28293, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Cost-Effectiveness Analysis of Erythropoietin in Anemia Therapy Strategies for Chronic Kidney Disease Patients Undergoing Hemodialysis: A Systematic Review Rosi Ami Sari; Seftika Sari; Dwi Endarti; Neni Frimayanti
JURNAL FARMASI DAN MAKANAN Vol 8 No 1 (2024): Journal of Pharmacy and Science
Publisher : LPPM Universitas Abdurrab

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Chronic kidney disease is a significant health issue, with increasing case numbers leading to higher treatment costs. This condition causes decreased kidney function and can result in anemia due to impaired red blood cell production. This study aims to analyze the cost-effectiveness of anemia treatment using Erythropoietin, either as a single therapy or in combination, for patients with chronic kidney failure undergoing hemodialysis. The methods employed include conducting a systematic review to identify problems, establish inclusion and exclusion criteria, and search various databases for relevant studies. The results show that cost-effectiveness varies depending on the Hemoglobin target and the type of Erythropoietin used. In conclusion, setting an appropriate Hemoglobin target and selecting the correct type of Erythropoietin are crucial for effective anemia treatment. This systematic review recommends a Hemoglobin target of >10–11 g/dL and the use of Erythropoietin is adjusted to the patient's condition so that the choice is more cost effective.
Analisis Hubungan Pelayanan Kefarmasian Terhadap Tingkat Kepuasan Pasien Program Rujuk Balik (PRB) BPJS Kesehatan Di Apotek Se-Kota Pekanbaru : Pendekatan Berbasis SERVQUAL Afriani Hasan; Seftika Sari; Indriyati Hadi Ningrum
JURNAL FARMASI DAN MAKANAN Vol 9 No 1 (2025): Journal of Pharmacy and Science
Publisher : LPPM Universitas Abdurrab

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36341/jops.v9i1.6868

Abstract

The Chronic Disease Referral Program (Program Rujuk Balik/PRB) of the Indonesian National Health Insurance (BPJS Kesehatan) is designed to ensure continuity of care for patients with chronic diseases through affiliated community pharmacies. The success of this program is not only determined by drug availability but also by the implementation of pharmaceutical care standards that emphasize patient-centered services. This study aimed to analyze the characteristics of PRB patients, assess the implementation of pharmaceutical care standards in PRB pharmacies, evaluate patient satisfaction based on SERVQUAL dimensions, and examine the relationship between pharmaceutical service standards and patient satisfaction. This research employed a descriptive analytic design with a cross-sectional approach. A total of 140 PRB patients were recruited using proportional random sampling from affiliated pharmacies in Pekanbaru. Data were collected using patient characteristic questionnaires, observation checklists for pharmaceutical service standards, and the SERVQUAL instrument. Data analysis was performed using univariate, bivariate (Chi-Square test), and gap analysis. The results showed that most PRB patients were female (52.14%), middle-aged adults 41–60 years (62.86%), with secondary education (50.0%), occupations mainly entrepreneurs (38.57%), and monthly income above IDR 3,508,776 (57.9%). The overall implementation of pharmaceutical service standards was good (82.73%), with drug management (85%), clinical services (56.25%), human resources (90%), and facilities (100%). Patient satisfaction was categorized as very satisfied, with the highest score in empathy (95.93%) and the lowest in tangibles (90.35%). The Chi-Square test indicated a significant relationship between the implementation of pharmaceutical care standards and patient satisfaction (p = 0.002). In conclusion, PRB patient satisfaction in Pekanbaru was very high, yet clinical pharmacy services still require improvement. It is recommended that pharmacies strengthen counseling, therapy monitoring, and adverse drug reaction reporting to enhance both patient satisfaction and long-term clinical quality.